Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders

  • Read more about Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
European Patent
04030912.2
Filed on 1994-10-12

Lymphatic Draining Imaging Of Breast Cancer In Mice By Micro-Magnetic Resonance Mammo-Lymphangiograpy Using A Dendrimer-based Contrast Agent

  • Read more about Lymphatic Draining Imaging Of Breast Cancer In Mice By Micro-Magnetic Resonance Mammo-Lymphangiograpy Using A Dendrimer-based Contrast Agent
Patent Cooperation Treaty
PCT/US2005/01388
Filed on 2005-01-12

Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use

  • Read more about Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use
Japan
2002-292578
Filed on 2002-10-04

Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use

  • Read more about Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use
European Patent
02256854.7
Filed on 2002-10-02

Backbone-Substituted Bifunctional DOTA Ligands, Complexes and Compositions Thereof, and Methods of Using Same

  • Read more about Backbone-Substituted Bifunctional DOTA Ligands, Complexes and Compositions Thereof, and Methods of Using Same
European Patent
03752034.3
Filed on 2003-09-05

Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same

  • Read more about Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same
Canada
2495442
Filed on 2003-09-05

Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same

  • Read more about Backbone Substituted Bifunctional DOTA Ligands, Complexes and Compositions thereof, and Methods of Using Same
Australia
2003270347
Filed on 2003-09-05

Backbone Substituted Bifunctional DOTA Ligands, Complexes, and Compositions Thereof, and Methods of Using Same

  • Read more about Backbone Substituted Bifunctional DOTA Ligands, Complexes, and Compositions Thereof, and Methods of Using Same
US Patent 7,368,100
Filed on 2005-04-18

Structure-based Design Of B1,4-Galactosyltransferase I (B4Gal-T1) That Is Dependent On Magnesium For Its Activity: POINT MUTATION, Met 344 To His Of B4Gal-T1 (Gal-T1-M344H), Changes The Metal Requirement From Manganese To Magnesium

  • Read more about Structure-based Design Of B1,4-Galactosyltransferase I (B4Gal-T1) That Is Dependent On Magnesium For Its Activity: POINT MUTATION, Met 344 To His Of B4Gal-T1 (Gal-T1-M344H), Changes The Metal Requirement From Manganese To Magnesium
Patent Cooperation Treaty
PCT/US2004/040844
Filed on 2004-12-06

Composition For Detecting the Response Of Rectal Adenocarcinomas to Radiochemotherapy

  • Read more about Composition For Detecting the Response Of Rectal Adenocarcinomas to Radiochemotherapy
Patent Cooperation Treaty
PCT/US2005/00891
Filed on 2005-01-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1091
  • Page 1092
  • Page 1093
  • Page 1094
  • Page 1095
  • Page 1096
  • Page 1097
  • Page 1098
  • Page 1099
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health